Investment Thesis
Modular Medical exhibits severe fundamental distress with massive operating losses (-$21.9M), negative cash flow generation (-$20.9M), and profitability margins in the millions of percent negative range. The company is burning cash while generating minimal revenue, indicating fundamental business model dysfunction rather than temporary operational challenges.
Strengths
- Positive current ratio of 1.59x indicates near-term liquidity capacity to cover obligations
- Zero debt burden eliminates leverage risk and solvency concerns
- Cash position of $2.9M provides runway for operations
Risks
- Operating cash outflow of -$17.9M annually is unsustainable with current asset base; company will deplete cash within months at current burn rate
- Revenue of $16M against $21.9M operating losses indicates severe cost structure problem and inability to achieve profitability at current scale
- Negative free cash flow of -$20.9M combined with ongoing capital expenditure of $2.9M demonstrates capital is being destroyed rather than generated
- Extreme profitability metrics (operating margin -136731250%, net margin -136575000%) suggest systemic operational dysfunction
- Diluted EPS of -$0.37 shows per-share value destruction despite modest YoY improvement
Key Metrics to Watch
- Operating cash flow trajectory - critical survival metric given current negative -$17.9M burn rate
- Revenue growth sustainability and gross margin realization - minimal revenue with zero gross profit indicates fundamental product/pricing dysfunction
- Cash depletion timeline - with $2.9M cash and -$20.9M annual FCF burn, runway is approximately 1.7 months
Financial Metrics
Revenue
16.0
Net Income
-21.9M
EPS (Diluted)
$-0.37
Free Cash Flow
-20.9M
Total Assets
10.3M
Cash
2.9M
Profitability Ratios
Gross Margin
0.0%
Operating Margin
-136,731,250.0%
Net Margin
-136,575,000.0%
ROE
-371.6%
ROA
-213.0%
FCF Margin
-130,406,250.0%
Balance Sheet & Liquidity
Current Ratio
1.59x
Quick Ratio
1.59x
Debt/Equity
0.00x
Debt/Assets
42.7%
Interest Coverage
-7.95x
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-04-02T04:16:11.264038 |
Data as of: 2025-12-31 |
Powered by Claude AI